Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing experiments for an ACL paper, covering tuned LLM baselines, multi-dataset and multilingual evaluation, statistical significance and variance, human evaluation with agreement reporting, contamination and prompt-sensitivity controls, ablations, and error-analysis expectations in NLP reviewing.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
Use this while the experimental story can still change. The ACL evidence bar is not "beats the baseline once": it is a defensible measurement of a language capability, with the failure modes examined.
| Result flavor | Required rigor at ACL |
|---|---|
| Small deltas between systems | Significance test (bootstrap/permutation) or overlapping-interval honesty |
| Fine-tuning results | Multiple seeds; mean and deviation in the table, defined in the caption |
| Prompted-LLM results | Multiple prompt paraphrases and/or samples; sensitivity range reported |
| Human evaluation | Raters per item, agreement statistic (e.g., Krippendorff's alpha), pay disclosed |
| Correlation claims (metrics) | Confidence intervals and comparison against existing metric correlations |
The Responsible NLP checklist (Section C) asks for descriptive statistics and error bars — an experiment plan that cannot fill Section C truthfully is incomplete by construction.
The distinctive ACL expectation: a quantitative error analysis with named categories.
Claim: <one sentence>
Datasets: <n, why these, language list>
Baselines: <incl. tuned LLM baseline + trivial floor>
Runs/variance: <seeds or prompt paraphrases; interval type>
Significance: <test, when applied>
Human eval: <items, raters, agreement plan, pay>
Contamination: <audit method>
Ablations: <component -> table row>
Error analysis:<sample size, category plan>
[Evidence verdict] convincing / thin / misaligned-with-claim
[Baseline gaps] <missing or under-tuned comparators>
[Statistical gaps] <variance/significance/agreement omissions>
[Validity threats] <contamination/leakage/label-quality>
[Highest-value next run] <one experiment>
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
日本語の概要は準備中です。原文の説明を表示しています。
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
日本語の概要は準備中です。原文の説明を表示しています。
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
日本語の概要は準備中です。原文の説明を表示しています。
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
日本語の概要は準備中です。原文の説明を表示しています。
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
日本語の概要は準備中です。原文の説明を表示しています。